1. Beyond its antioxidant properties: Quercetin targets multiple signalling pathways in hepatocellular carcinoma in rats
    Yasmin Ahmed Salama et al, 2019, Life Sciences CrossRef
  2. Hepatitis B Virus preS2 Domain Promotes Angiogenesis in Hepatocellular Carcinoma via Transcriptional Activation of VEGFA Promoter
    Fang Luan et al, 2021, Hepatitis Monthly CrossRef
  3. Current therapeutic modalities and chemopreventive role of natural products in liver cancer: Progress and promise
    Amit Kumar Singh et al, 2023, World Journal of Hepatology CrossRef
  4. Mechanisms of Hepatitis B Virus-Induced Hepatocarcinogenesis
    Jiyoung Lee et al, 2021, Viruses and Human Cancer CrossRef
  5. Notch signaling pathway in infectious diseases: role in the regulation of immune response
    Ricardo Cardoso Castro et al, 2021, Inflammation Research CrossRef
  6. Exploring the role of CDCA4 in liver hepatocellular carcinoma using bioinformatics analysis and experiments
    Changfu Liang et al, 2024, Medicine CrossRef
  7. Association of hypoxia-inducible factor 1α expression with susceptibility to hepatitis B virus-related hepatocellular carcinoma: A meta-analysis
    Lei Wang et al, 2023, The International Journal of Biological Markers CrossRef
  8. The Notch-3 receptor: A molecular switch to tumorigenesis?
    Shakeel Inder et al, 2017, Cancer Treatment Reviews CrossRef
  9. The Role of Notch3 in Cancer
    Zviadi Aburjania et al, 2018, The Oncologist CrossRef
  10. Notch Signaling and Liver Cancer
    Kazunori Kawaguchi et al, 2021, Notch Signaling in Embryology and Cancer CrossRef
  11. Hypoxia-inducible factor-1α and poly [ADP ribose] polymerase 1 cooperatively regulate Notch3 expression under hypoxia via a noncanonical mechanism
    Hideaki Nakamura et al, 2022, Journal of Biological Chemistry CrossRef
  12. Notch Signaling Regulation in HCC: From Hepatitis Virus to Non-Coding RNAs
    Catia Giovannini et al, 2021, Cells CrossRef
  13. Oncogenic signaling pathway mediated by Notch pathway-related genes induces immunosuppression and immunotherapy resistance in hepatocellular carcinoma
    Peng Ma et al, 2022, Immunogenetics CrossRef

  14. Glucometabolic Reprogramming in the Hepatocellular Carcinoma Microenvironment: Cause and Effect


    Huining Tian et al, 2020, Cancer Management and Research CrossRef
  15. Hepatitis B x (HBx) as a Component of a Functional Cure for Chronic Hepatitis B
    Mark A. Feitelson et al, 2022, Biomedicines CrossRef
  16. Hypoxia Activates Notch4 via ERK/JNK/P38 MAPK Signaling Pathways to Promote Lung Adenocarcinoma Progression and Metastasis
    Xiaochen Li et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
  17. Dysregulated cell-signaling pathways in hepatocellular carcinoma: causes and therapeutic options
    Vinit Singh Baghel et al, 2022, Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2 CrossRef
  18. Hepatitis B X protein upregulates decoy receptor 3 expression via the PI3K/NF-κB pathway
    Dong-Yu Liang et al, 2019, Cellular Signalling CrossRef
  19. The immunological role of ADAMs in the field of gastroenterological chronic inflammatory diseases and cancers: a review
    Jun Arai et al, 2023, Oncogene CrossRef
  20. Hepatitis B virus upregulates GP73 expression by activating the HIF-2α signaling pathway
    Sheng‑Li Yang et al, 2018, Oncology Letters CrossRef